Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous nandrolone decanoate in healthy male volunteers
ACTRN12613000068763Phase 4Completed
- Sponsor
- Sydney Local Health District
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of nandrolone in Hypoandrogenism (TD), sponsored by Sydney Local Health District. Primary endpoint: Time profile of serum testosterone concentrations. Started Apr 2013; status: completed.
02
Drugs
nandrolone
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on ACTRN12613000068763.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000068763.